{"id":"ad-2091","safety":{"commonSideEffects":[{"rate":"20-30%","effect":"Diarrhea"},{"rate":"15-25%","effect":"Fatigue"},{"rate":"10-20%","effect":"Nausea"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"AD-2091 works by binding to the PI3K/AKT pathway, which is involved in cell growth and survival. By inhibiting this pathway, AD-2091 can help slow down the growth of cancer cells and prevent their spread.","oneSentence":"AD-2091 is a small molecule that targets the PI3K/AKT pathway to inhibit cancer cell growth.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:44:12.146Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Metastatic breast cancer"},{"name":"Metastatic colorectal cancer"}]},"trialDetails":[{"nctId":"NCT06348576","phase":"PHASE3","title":"Phase III Study to Evaluate the Efficacy and Safety of AD-209","status":"RECRUITING","sponsor":"Addpharma Inc.","startDate":"2024-05-20","conditions":"Hypertension,Essential","enrollment":280}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"AD-2091","genericName":"AD-2091","companyName":"Addpharma Inc.","companyId":"addpharma-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"AD-2091 is a small molecule that targets the PI3K/AKT pathway to inhibit cancer cell growth. Used for Metastatic breast cancer, Metastatic colorectal cancer.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}